New Enterprise Associates 14, L.P. Insider Trading $OYST Oyster Point Pharma, Inc.
Get free email notifications about insider trading for New Enterprise Associates 14, L.P..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of New Enterprise Associates 14, L.P.. New Enterprise Associates 14, L.P. is 10% Owner in MULESOFT, INC ($MULE) and 10% Owner in Tracon Pharmaceuticals, Inc. ($TCON) and 10% Owner in APPIAN CORP ($APPN) and 10% Owner in Mersana Therapeutics, Inc. ($MRSN) and 10% Owner in Mirna Therapeutics, Inc. ($MIRN) and 10% Owner in Cerecor Inc. ($CERC) and 10% Owner in Galera Therapeutics, Inc. ($GRTX) and 10% Owner in Loxo Oncology, Inc. ($LOXO) and 10% Owner in Casper Sleep Inc. ($CSPR) and 10% Owner in Adaptimmune Therapeutics PLC ($ADAP) and 10% Owner in IMARA Inc. ($IMRA) and 10% Owner in Oyster Point Pharma, Inc. ($OYST) and 10% Owner in Surface Oncology, Inc. ($SURF).
New Enterprise Associates 14, L.P. in Oyster Point Pharma, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of New Enterprise Associates 14, L.P.: 10% Owner
Holdings: 3,928,740 shares
Latest Transaction: Nov 04 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of New Enterprise Associates 14, L.P. in Oyster Point Pharma, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADAP, APPN, CSPR, CERC, GRTX, IMRA, LOXO, MRSN, MULE, OYST, SURF, SYBX, TCON
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 04 2019 | OYST | Oyster Point Pharm ... | New Enterprise Associates 14, ... | 10% Owner | Option Exercise | C | 0.00 | 1,061,547 | 0 | 0 | |
| Nov 04 2019 | OYST | Oyster Point Pharm ... | New Enterprise Associates 14, ... | 10% Owner | Option Exercise | C | 0.00 | 3,606,282 | 0 | 0 | |
| Nov 04 2019 | OYST | Oyster Point Pharm ... | New Enterprise Associates 14, ... | 10% Owner | Buy | P | 16.00 | 935,000 | 14,960,000 | 5,925,287 | 5 M to 5.9 M (+18.74 %) |
| Nov 04 2019 | OYST | Oyster Point Pharm ... | New Enterprise Associates 14, ... | 10% Owner | Buy | C | 0.00 | 1,061,547 | 0 | 4,990,287 | 3.9 M to 5 M (+27.02 %) |
| Nov 04 2019 | OYST | Oyster Point Pharm ... | New Enterprise Associates 14, ... | 10% Owner | Buy | C | 0.00 | 3,606,282 | 0 | 3,928,740 | 322.5 K to 3.9 M (+1,118.37 %) |
Page: 1